Eric Dobmeier, President, CEO at CHINOOK THERAPEUTICS, INC. (KDNY), bought 2,000 shares at $12.00 ($24K) on 2021-09-20, disclosed to the SEC on 2021-09-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KDNY | SELL | 2023-02-15 | $385K | — | Filing → |
| KDNY | SELL | 2023-02-01 | $993K | — | Filing → |
| KDNY | SELL | 2022-12-02 | $669K | — | Filing → |